BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 24996171)

  • 1. Laryngeal cancer in Finland: A 5-year follow-up study of 366 patients.
    Haapaniemi A; Koivunen P; Saarilahti K; Kinnunen I; Laranne J; Aaltonen LM; Närkiö M; Lindholm P; Grénman R; Mäkitie A; Atula T;
    Head Neck; 2016 Jan; 38(1):36-43. PubMed ID: 24996171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transoral laser microsurgery in treatment of pT2 and pT3 glottic laryngeal squamous cell carcinoma - results of 391 patients.
    Canis M; Martin A; Ihler F; Wolff HA; Kron M; Matthias C; Steiner W
    Head Neck; 2014 Jun; 36(6):859-66. PubMed ID: 23720321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein marker profiling in different T classification in laryngeal squamous cell carcinoma.
    Chen W; Ye F; Cui M; Sikora AG; Wang X; Wang P; Cui X; Guo X; Zhu W; Zhang DY
    Head Neck; 2015 Mar; 37(3):357-65. PubMed ID: 24753215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive factors and treatment outcome of laryngeal carcinoma recurrence.
    Haapaniemi A; Väisänen J; Atula T; Alho OP; Mäkitie A; Koivunen P
    Head Neck; 2017 Mar; 39(3):555-563. PubMed ID: 27902867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of laryngeal edema after partial laryngectomy and radiotherapy in supraglottic cancer.
    Oksüz DC; Uzel O; Yildirim A; Yetmen O; Sahinler I; Turkan S
    J Otolaryngol Head Neck Surg; 2008 Oct; 37(5):681-8. PubMed ID: 19128676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of 226 patients with T3 laryngeal carcinoma after treatment with transoral laser microsurgery.
    Canis M; Ihler F; Martin A; Wolff HA; Matthias C; Steiner W
    Head Neck; 2014 May; 36(5):652-9. PubMed ID: 23596018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supraglottic laryngeal cancer: analysis of treatment results.
    Sessions DG; Lenox J; Spector GJ
    Laryngoscope; 2005 Aug; 115(8):1402-10. PubMed ID: 16094113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of T3N0M0 glottic carcinoma: therapeutic outcomes.
    Sessions DG; Lenox J; Spector GJ; Newland D; Simpson J; Haughey BH; Chao KS
    Laryngoscope; 2002 Jul; 112(7 Pt 1):1281-8. PubMed ID: 12169914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcomes after surgical or nonsurgical initial therapy for patients with T4 squamous cell carcinoma of the larynx: A 3-decade survey.
    Rosenthal DI; Mohamed AS; Weber RS; Garden AS; Sevak PR; Kies MS; Morrison WH; Lewin JS; El-Naggar AK; Ginsberg LE; Kocak-Uzel E; Ang KK; Fuller CD
    Cancer; 2015 May; 121(10):1608-19. PubMed ID: 25586197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
    Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
    Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The management of glottic and supraglottic cancers of the larynx in relation to neck metastasis.
    Yücetürk AV; Celik O; Eskiizmir G
    Kulak Burun Bogaz Ihtis Derg; 2003 Nov; 11(5):129-33. PubMed ID: 15542939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic outcomes of laryngeal cancer at Kyoto University Hospital for 10 years.
    Tamura Y; Tanaka S; Asato R; Hirano S; Yamashita M; Tamaki H; Ito J
    Acta Otolaryngol Suppl; 2007 Feb; (557):62-5. PubMed ID: 17453448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncologic outcomes in advanced laryngeal squamous cell carcinomas treated with different modalities in a single institution: a retrospective analysis of 65 cases.
    Bussu F; Miccichè F; Rigante M; Dinapoli N; Parrilla C; Bonomo P; Cadoni G; Mantini G; Galli J; Rufini V; Almadori G; Valentini V; Paludetti G
    Head Neck; 2012 Apr; 34(4):573-9. PubMed ID: 21692130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of T3N1 glottic carcinoma: therapeutic outcomes.
    Spector JG; Sessions DG; Lenox J; Simpson J
    Laryngoscope; 2006 Jan; 116(1):106-10. PubMed ID: 16481820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment, comorbidity and survival in stage III laryngeal cancer.
    Connor KL; Pattle S; Kerr GR; Junor E
    Head Neck; 2015 May; 37(5):698-706. PubMed ID: 24596316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minichromosome maintenance protein 7 and geminin expression: Prognostic value in laryngeal squamous cell carcinoma in patients treated with radiotherapy and cetuximab.
    Almadori G; Lauriola L; Coli A; Bussu F; Gallus R; Scannone D; Valentini V; Paludetti G; Carey TE; Ranelletti FO
    Head Neck; 2017 Apr; 39(4):684-693. PubMed ID: 28032719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased local control following radiation therapy alone in early-stage glottic carcinoma with anterior commissure extension.
    Zouhair A; Azria D; Coucke P; Matzinger O; Bron L; Moeckli R; Do HP; Mirimanoff RO; Ozsahin M
    Strahlenther Onkol; 2004 Feb; 180(2):84-90. PubMed ID: 14762660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of definitive radiotherapy for squamous cell carcinomas of the larynx patients with subglottic extension].
    Lévy A; Blanchard P; Janot F; Temam S; Bourhis J; Daly-Schveitzer N; Tao Y
    Cancer Radiother; 2014 Jan; 18(1):1-6. PubMed ID: 24309002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary total laryngectomy versus organ preservation for T3/T4a laryngeal cancer: a population-based analysis of survival.
    Dziegielewski PT; O'Connell DA; Klein M; Fung C; Singh P; Alex Mlynarek M; Fung D; Harris JR; Seikaly H
    J Otolaryngol Head Neck Surg; 2012 Apr; 41 Suppl 1():S56-64. PubMed ID: 22569051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment results and prognostic factors for advanced squamous cell carcinoma of the larynx treated with concurrent chemoradiotherapy.
    Taguchi T; Nishimura G; Takahashi M; Komatsu M; Sano D; Sakuma N; Arai Y; Yamashita Y; Shiono O; Hirama M; Sakuma Y; Ishitoya J; Hata M; Ogino I; Oridate N
    Cancer Chemother Pharmacol; 2013 Oct; 72(4):837-43. PubMed ID: 23959463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.